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Abstract 
BACKGROUND: Left ventricular (LV) volumes and ejection fraction (EF) is Strong prognostic indicators for DCM. 
Cardiac MRI (CMRI) is a preferred technique for LV volumes and EF assessment due to high spatial resolution 
and complete volumetric datasets. Three-dimensional echocardiography is a promising new technique under 
investigations. 
AIM: Evaluate 3D echocardiography as a tool in LV assessment in DCM children about CMRI.  
PATIENTS AND METHODS: A group of 20 DCM children (LVdiastolic diameter < 2 Z score, LVEF < 35%) at 
Children s Hospital, Ain-Shams University (gp1) (mean age 6.6 years) were compared to 20 age and sex-
matched children as controls (gp2). Patients were subjected to: clinical examination, conventional 
echocardiography, automated 3D LV quantification, 3D speckle tracking echocardiography (3D-STE) (VIVID E9 
Vingmed, Norway) and CMRI (Philips Achieva Nova, 1.5 Tesla scanner) for LV end systolic volume (LVESV), 
LVend diastolic volume (LVEDV) that were indexed to body surface area, EF% and wall motion abnormalities 
assessment.  
RESUTS: No statistically significant difference was found between automated 3D LV quantification 
echocardiography, 3D-STE, and CMRI in ESV/BSA and EDV/BSA assessment (p = 1, 0.99 respectively), 
between automated LV quantification echocardiography and CMRI in EF% assessment (p = 0.99) and between 
CMRI and 3D-STE in LV Global hypokinesia detection (P = 0.255). As for segmental hypokinesia CMRI was more 
sensitive [45% of patients vs. 40%, (P = 0,036), basal septal hypokinesia 85% vs. 75%, (p = 0.045), mid septal 
hypokinesia 80% vs. 65%, (p = 0.012) and lateral wall hypokinesia 75% vs. 65%, (p = 0.028)]. 
CONCLUSION: Automated 3D LV quantification echocardiography and 3D-STE are reliable tools in LV volumetric 
and systolic function assessment about CMRIas a standard method. 3D speckle echocardiography is comparable 
to CMRI in global wall hypokinesia detection but less sensitive in segmental wall hypokinesia which mandates 
further studies. 
 
 
 
 
 
 
Introduction 
 
Pediatric dilated cardiomyopathy (DCM) is a 
serious often life-threatening condition. Left ventricular 
(L V) volumes and LV ejection fraction (EF) provide 
fundamental measures of function and are Strong 
prognostic indicators for patients with DCM [1]. In 
DCM, LV ejection fraction is the strongest predictor of 
progression to heart failure, while LV volume and 
mass are independently correlated with mortality and 
morbidity; therefore accurate quantification of all these 
parameters is essential for adequate patient’s 
evaluation and also to monitor the progression of 
disease and response to different therapeutic agents 
[2]. CMR can be considered the reference technique 
for the quantification of ventricular volumes and 
functional parameters and ventricular mass in patients 
with DCM [3]. 
Three dimensional (3D) and 3D speckle 
tracking are promising new techniques that are still 
under investigations. The aim of the current study was 
To evaluate 3D echocardiography as a tool of LV 
assessment in children with DCM about CMR 
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Patients and Methods 
 
The current cross-sectional study was 
conducted on 20 children with idiopathic dilated 
cardiomyopathy (IDCM) (LVdiastolic diameter > 2 Z 
score, LVEF < 35%) [4], attending the Pediatric 
Cardiology Clinic, Children’s Hospital, Ain-Shams 
University (10 males and 10 females), and their ages 
ranged from 1 month to 14 years with a mean age of 
6.6 years (gp1) that were compared to 20 age and 
sex-matched children as controls (gp2). Patients with 
any known cause of myocardial disease, underlying 
congenital heart disease, hypertrophic 
cardiomyopathy or secondary DCM, renal 
insufficiency (plasma creatinine > 2mg/dl), hepatic, 
autoimmune disorders or malignancies were excluded 
from the study. Informed consent was taken from 
parents/caregivers. The study was approved by the 
ethical committee. Studied groups were subjected to: 
- Thorough history taking: laying stress on 
symptoms of heart failure, NYHA heart failure 
classification 
- Detailed clinical examination with special 
emphasis on cardiac examination. 
- Echocardiographic imaging. 
Initially routine diagnostic imaging was 
performed and included Motion mode (M mode), two-
dimensional echo (2D), Pulsed wave (PW), Continous 
wave (CW), as well as Colour flow (CF) Doppler 
studies. The following parameters were assessed by 
M-mode of left ventricle in short axis parasternal 
views: Left Ventricular End Systolic Volume (LVESV 
(ml), Left Ventricular End Diastolic Volume (LVEDV 
(ml), Ejection Fraction (EF%) Echocardiographic 
examinations were performed in a standard manner with 
use of a commercially available cardiac ultrasound unit 
device model (VIVId E9 ultrasound system, General 
electric Vingmed, Horten, Norway). 
First, six-chamber views, as well as three 
short-axis views at different levels of the left ventricle 
from base to apex, were automatically selected from 
the RT3DE pyramidal dataset in the first time frame of 
the dataset, i.e. end-diastole. Then the anatomically 
correct, non-foreshortened apical views were 
identified by finding the largest long-axis dimensions. 
In these two planes, LV endocardial boundaries were 
manually initialised, while including the papillary 
muscles in the LV cavity. Then, the 3D endocardial 
surface was automatically reconstructed and tracked 
in 3D throughout the cardiac cycle. Finally, the 
endocardial surface was manually adjusted when 
necessary in the above five planes until the best 
match was visually verified. For each consecutive time 
frame, voxel count inside the detected endocardial 
surface was used to calculate LV volume. End-
diastolic volume and ESV were then obtained from the 
LV volume curves as the maximum and minimum 
values, respectively, as well as detecting values of 
longitudinal strain and expressed as a percentage of 
the original length. The patient is considered to have 
wall motion abnormality if any segment showed 
longitudinal strain < 11 [5]. 
Pyramidal RT3DE datasets were analysed 
using the 3D wall motion tracking software (VIVId E9 
ultrasound system (General Electric, Vingmed, 
Horten, Norway)) by an investigator experienced with 
STE analysis that was blinded to the results of cMRI 
measurements.  
A Philips Achieva Nova (1.5 teslas) scanner 
superconducting system with 30 mt/mint gradient with 
cardiac coil was used in Radiology department (MRI 
unit) Ain Shams University for assessment of Ejection 
Fraction (EF%, End Systolic Volume (ESV) End 
Diastolic Volume (EDV). 
The procedures of the MR examination were 
explained to the patient above 7 years old including 
breath hold instructions. The patients were briefly 
interviewed about MR contraindications, whether the 
patient has a pacemaker or any other implanted 
devices, or other foreign materials inside the body (in 
particular cerebral aneurysmal clips). Children below 7 
years sedated with chloral hydrate and their parents were 
informed by precautions.  
Patients were studied in the supine position, 
head first. The patients were offered cotton blankets 
for warmth. Headphones with the MRI machine were 
used to reduce repetitive gradient noise and at the 
same time allow the patients to hear the breath-hold 
instructions. 
The first electrode was placed approximately 
1 cm left of the xiphoid. The second and third 
electrodes (were positioned in such a way that they 
were aligned at approximately 90 degrees to each 
other, where the first electrode forms the right angle. 
The distance between the electrodes should be 
approximately 15 cm. The fourth electrode was placed 
below the first electrode. It was used to determine the 
cardiac frequency as it should be close to the patient’s 
heart rate. The QRS complex was then checked on 
MRI monitor, adjustment of the site of the leads was 
made accordingly. The patient’s heart rate was also 
detected on MRI monitor. 
The respiratory sensor was placed over the 
maximum area of respiratory movement (abdomen 
and thorax) under the coil. A strap was used to fix the 
sensor. The respiratory signal was then checked as 
the respiratory wave appeared on the monitor and 
was used to detect the patient’s respiratory rhythm 
and synchronise breath hold instructions to the 
patient's abilities.  
The SENSE (sensitivity encoding) cardiac coil 
(6 elements phased array coil, receive only) was 
used. It has a rigid lower part and a flexible upper 
part. The coil was positioned on the chest so that the 
midline of its upper part lied just below the 
sternoclavicular notch and the lower part of the coil 
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lied underneath the patient. It was carefully strapped 
onto the patient. The connection to the magnet was 
checked. 
Planning vertical long axis image from the 
axial orthogonal image at the level of the left ventricle, 
planning the horizontal long axis view from the vertical 
long axis view. Planning the short axis view from the 
horizontal long axis view. Breath-hold balanced turbo 
field echo sequence (b-TFE) in short axis view from 
the mitral annulus to the apex with the following 
parameters: TR (repetition time)/TE (echo time): 
4.4/2.5, FOV (Field of view): 300, Phases: 25, NSA 
(Number of signal averages): 1, Flip angle: 15, Scan 
time: 7-12 sec, Slice thickness: 8 mm, Number of 
slices: 7. 
Analysis of the CMR (DICOM) images was 
performed using Brilliance 170 P workstation. Left 
ventricular ejection fraction and volumes were 
quantified automatically from the cine images after 
manual tracing of LV endocardial border in the short 
axis images during end systole and end diastole for 
each slice position. 
 
 
 
Results 
 
Sixty-five per cent of studied patients (65%) 
were males and (35%) were females with males to 
females 2:1. 
Thirty per cent of studied patients (30%) had 
increased heart rate for age, 55% had low systolic 
blood pressure for age, and 35% had low diastolic 
blood pressure for age. 
Table 1: Comparison between 3D echocardiography, cMRI and 
3D speckle echocardiography regarding ESV (ml) and EDV (ml) 
values indexed by BSA (m
2
) and EF (%) mean values 
 
3D echocardiography cMRI 3D speckle One Way ANOVA 
Mean SD Mean SD Mean SD F P-value 
ESV (ml)/BSA (m
2
) 58.58 23.89 58.65 24.11 58.58 23.88 0.000 1.000 (NS) 
EDV (ml)/BSA (m
2
) 92.69 27.44 93.41 27.33 92.84 27.29 0.004 0.996 (NS) 
EF (%) 40.25 7.65 39.56 9.80 - - 4.817 0.996 (NS) 
One Way ANOVA comparing three groups, P-value > 0.05 is non-significant, SD: Standard 
deviation, ESV: End Systolic Volume, EDV: End Diastolic Volume, cMRI: cardiac Magnetic 
Resonant Imaging, BSA: Body Surface Area, NS: Non-Significant. 
 
All patients were on Frusemide and Captopril 
therapy, 90% of them were on Digoxin and 
Spironolactone, 35% were on low dose aspirin, and 
20% of them were on L-carnitine.  
A statiscally significant increase was found in 
patients ESV/BSA and EDV/BSA and a statistically 
significant decrease was found in patients EF% 
assessed by 3D-LV quantification compared to 
controls (58.58 ± 23.89 vs. 24.16 ± 1.58, p = 0.000; 
92.69 ± 27.44 vs. 61,24 ± 1.58, p = 0.001 and 40.25 ± 
7.65 vs. 69.4 ± 4.55, p = 0.00 respectively). 
Table 2: Comparison between cMRI and 3DSTE as regards 
cardiac wall motion abnormalities assessment 
 
CMRI 3D STE Chi-square test 
No. % No. % X
2
 P-value 
Global hypokinesia 16 80.0% 16 80.0% 2.727 0.255 NS 
Apical hypokinesia 9 45.0% 8 40.0% 6.624 0.036 S 
Septal wall dyskinesia 3 15.0% 2 10.0% 3.055 0.217 NS 
Basal septal hypokinesia 17 85.0% 15 75.0% 6.190 0.045 S 
Mid septal hypokinesia 16 80.0% 13 65.0% 8.750 0.012 S 
Inferior wall hypokinesia 14 70.0% 12 60.0% 5.253 0.072 NS 
Lateral wall hypokinesia 15 75.0% 13 65.0% 7.131 0.028 S 
Inferior wall akinesia  2 10.0% 1 5.0% 2.105 0.349 NS 
cMRI: Cardiac magnetic resonance imaging, 3DSTE: 3D speckle tracking echocardiography, P 
value > 0.05 is non-significant, P value < 0.05 is significant, NS: Non Significant, S: Significant. 
 
A statistically significant increase was found in 
patients ESV/BSA and EDV/BSA assessed by 3D-
STE compared to controls (58.58 ± 23.88 vs. 24.16 ± 
15.8, p = 0.000 and 92.84 ± 27.29 vs. 61.24 ± 2.84, p 
= 0.001 respectively). 
Also, a stastically significant increase was 
found in patients ESV/BSA and EDV/BSA and a 
statistically significant decrease was found in patients 
EF%assessedbyCMRI compared to controls (58.65 ± 
24.11 vs. 26.02 ± 1.77, p = 0.000; 93.41 ± 27.33 vs. 
63.03 ± 3.05, p = 0.002 and 39.56 ± 9.8 vs. 67.65 ± 
3.07, p = 0.000 respectively). 
Table 3: Intraobserver variability of 3DSTE regarding wall 
motion abnormalities 
3DSTE 
Observer. I Observer. II Chi-square test 
No. % No. % X
2
 P-value 
Global hypokinesia 16 80.0% 13 65.0% 0.864 0.3526 NS 
Apical hypokinesia 8 40.0% 6 30.0% 0.110 0.7403 NS 
Septal wall dyskinesia 2 10.0% 1 5.0% 0.000 1.0000 NS 
Basal septal hypokinesia 15 75.0% 13 65.0% 0.119 0.7301 NS 
Mid septal hypokinesia 13 65.0% 11 55.0% 0.114 0.7469 NS 
Inferior wall hypokinesia 12 60.0% 10 50.0% 0.101 0.7506 NS 
Lateral wall hypokinesia 13 65.0% 11 55.0% 0.104 0.7469 NS 
Inferior wall akinesia  1 5.0% 1 5.0% 0.545 0.4602 NS 
3DSTE: 3D speckle track echocardiography, P value > 0.05 is non significant, NS: Non 
Significant, Observ: Observation. 
 
No statistically significant difference was 
found between automated 3D LV quantification 
echocardiography, 3D-speckle echocardiography, and 
cMRI in assessment of ESV/BSA (58.58 ± 23.89 
ml/m
2
), (58.58 ± 23.88 ml/m
2
), (58.65 ± 24.11ml/m
2
) 
respectively and EDV/BSA (92.69 ± 27.44 ml/m
2
), 
(92.84 ± 27.29 ml/m
2
), (93.41 ± 27.33 ml/m
2
) 
respectively No statistically significant difference was 
found between automated LV quantification 
echocardiography and CMRI in EF% values (40.25 ± 
7.65 vs. 39.56 ± 9.8, p = 0.99). All studied patients 
had global and segmental hypokinesia as assessed 
by 3D-STE and CMRI. 
Table 4: Intraobserver variability of cMRI regarding wall motion 
abnormalities 
cMRI 
Observer. I Observer. II Chi-square test 
No. % No. % X
2
 P-value 
Global hypokinesia 16 80.0% 14 70.0% 0.133 0.715 NS 
Apical hypokinesia 9 45.0% 7 35.0% 0.104 0.746 NS 
Septal wall dyskinesia 3 15.0% 1 5.0% 0.144 0.0578 NS 
Basal septal hypokinesia 17 85.0% 15 75.0% 0.158 0.6926 NS 
Mid septal hypokinesia 16 80.0% 13 65.0% 0.502 0.4788 NS 
Inferior wall hypokinesia 14 70.0% 12 60.0% 0.110 0.7403 NS 
Lateral wall hypokinesia 15 75.0% 13 65.0% 0.119 0.7301 NS 
Inferior wall akinesia  2 10.0% 0 0.0% 0.526 0.4682 NS 
cMRI: Cardiac magnetic resonance imaging, P-value > 0.05 is non significant, NS: Non 
Significant, Observer: Observation. 
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Parameters Cut off point AUC Sensitivity Specificity +PV -PV 
EDV(ml)/BSA(m
2
) by 
3D echocardiography 
>65.4 * 88.8 80.00 100.00 100.0 71.4 
ESV(ml)/BSA(m
2
) by 
3D echocardiography 
>26.6 100.00 100.00 100.00 100.00 100.0 
ESV: End Systolic Volume, EDV: End Diastolic Volume, BSA: Body Surface Area,+ PV: Positive Predictive 
Value, -PV: Negative Predictive Value, AUC: Area Under the Curve. 
Figure 1: ROC curve detect sensitivity and specificity of 3D 
echocardiography in the prediction of EDV and ESV indexed by 
BSA 
 
Sensitivity of 3D and 3D-STE 
echocardiography in prediction of EDV (ml)/BSA (m
2
) 
was 80% and 100% in prediction of ESV (ml) /BSA 
(m
2
) (Figures 1 and 2). Sensitivity and specificity of 
3D-echocardiography and cMRI were 100% in the 
assessment of EF% (Figure 3). 
 
Parameters Cut off point AUC Sensitivity Specificity +PV -PV 
EDV(ml)/BSA(m
2
) by 
3D-STE 
> 65.4 88.8 80.0 100.0 100.0 71.4 
ESV(ml)/BSA(m
2
) by 
3D-STE 
> 26.6 100.0 100.0 100.0 100.0 100.0 
ESV: End Systolic Volume, EDV: End Diastolic Volume, BSA: Body Surface Area,  
+ PV: Positive Predictive Value, -PV: Negative Predictive Value, AUC: Area Under the Curve. 
Figure 2: Sensitivity and specificity of 3D-STE in the prediction of 
EDV (ml) and ESV (ml) indexed by BSA (m
2
) 
 
No statistically significant intraobserver 
variability was found as regards ESV/BSA,EDV/BSA 
and assessed by 3D LV quantification (58.5 ± 2.3 vs. 
58.2 ± 3.5, p = 0.75 and 92.6 ± 3.5 vs. 92.3 ± 3.2, p = 
0.71 respectively). 
No statistically significant difference was 
found between CMRI and 3D-Speckle tracking 
echocardiography in detection of LV Global 
hypokinesia (P = 0.255). CMRI was found to be a 
better tool in segmental wall hypokinesia detection 
than 3D-STE [(apical hypokinesia 45% vs. 40%, (P = 
0,036), basal septal hypokinesia 85% vs. 75%, (p = 
0.045), mid-septal hypokinesia 80% vs. 65%, (p = 
0.012) and lateral wall hypokinesia 75% vs. 65%, (p = 
0.028). 
 
 
Parameters Cut off point AUC Sensitivity Specificity PPV NPV 
EF% by 3D <49 100.0 100.0 100.0 100.0 100.0 
EF by cardiac MRI  < 48.5 100.0 100.0 100.0 100.0 100.0 
 
 
 
 
PV: Positive Predictive Value, -PV: Negative Predictive Value, AUC: Area Under the Curve, cMRI Cardiac 
magnetic resonance imaging.   
Figure 3: ROC curve detect sensitivity and specificity of 3D 
echocardiography and cMRI in the prediction of EF 
 
Also, no statistically significant intraobserver 
variability was found as regards ESV/BSA, EDV/BSA 
and EF% assessed by 3D-STE ( 58.45 ± 3.7, p = 
0.923; 92.65 ± 3.4, p = 0.855) and no statistically 
significant intraobserver variability was found as 
regards EF% assessment by 3D LVquantification 
(40.25 ± 8.75 vs. 40.5 ± 7.95, p = 0.908) and by CMRI 
(39.56 ± 15 vs. 39.34 ± 15.8, p = 0.992). 
 Also, no statistically significant intraobserver 
variability was found as LV segmental wall motion 
abnormalities by 3D-STE and CMRI. 
 
 
Discussion 
 
The current study aimed to compare 3-D 
echocardiography versus cMRI in the assessment of 
left ventricular functions of children with dilated 
cardiomyopathy. 
Thirty per cent of studied patients (30%) had 
increased heart rate for age, 55% had low systolic 
blood pressure for age, and 35% of them had low 
diastolic blood pressure for age which came in 
accordance with Marx et al., 2013 and can be 
attributed to decreased cardiac output and 
medications received [6]. All studied patients were on 
Frusemide, and Captopril therapy, 90% of them were 
on Digoxin and Spironolactone, 35% were on low 
dose aspirin, and 20% of them were on L-carnitine 
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which agreed with Daubeney et al., (2006) who 
reported that long-term medical therapy for congestive 
heart failure is the main treatment strategy in patients 
with DCM and include diuretics, digoxin, afterload 
reducing agents (usually ACEI), an aldosterone 
antagonist and beta-blockers, they also added that 
congestive heart failure is severe among children with 
DCM and although early mortality is high, the clinical 
status of long-term survivors is good with adequate 
management [7]. 
 In the current study, no statistically significant 
difference was found between 3D-echocardiography 
and cMRI as regards EF% assessment (40.25 ± 25 vs 
39.56 ± 9.80%, p = 0.996). This agreed with Jenkins 
et al., (2004) and (Hoffmann et al., 2006) and 
disagreed with Feng Wang et al., (2009) who reported 
an overestimation of LVEF by 3D-echocardiography 
compared to CMRI (30 ± 7%:19 ± 8%), and explained 
this overestimation by the delay of cardiac MRI gating 
so that the first frame was not always end-diastolic, 
and therefore EDVs of Cardiac MRI was sometimes 
underestimated [8], [9], [10]. Also, by the assumption 
that, in hypocontractile and enlarged ventricles, the 
difference in temporal resolution between 3D-
echocardiography and cardiac MRI becomes less 
relevant than in contractile ventricles with a good 
LVEF or hypertrophy of the myocardial wall. 
No statistically significant difference was 
found between 3D-echocardiography, 3D-speckle 
echocardiography, and cMRI as regards ESV/BSA      
[ (58.58 ± 23.89 ml/m
2
), (58.58 ± 23.88 ml/m
2
), (58.65 
± 24.11 ml/m
2
) respectively (P = 1)] and EDV/BSA[ 
(92.69 ± 27.44 ml/m
2
), (92.84 ± 27.29 ml/m
2
), (93.41 ± 
27.33 ml/m
2
) respectively (P = 0.996)] which came in 
accordance with Gutierrez-Chico et al., (2005) and 
Hans-Joachim Nesser et al., (2009 )and disagreed 
with Hakan Demir et al., (2007) who reported that the 
values of EDV and ESV were under estimated by 
cMRI (EDV 91.1 ± 38.0 ml, ESV 41.8 ± 26.9 ml) 
compared to ECHO (EDV 127.5 ± 42.2 ml, ESV 59.9 
± 37.6 ml) and attributed this difference in their study 
to exclusion of basal portions of left ventricle and high 
spatial resolution of (CMRI) [11], [12], [13]. Hakan 
Demir et al., (2007) exclusion of major vascular 
structures and valves from ventricular volume slices of 
CMRI were minimally repositioned to the 
midventricular region at the base of the heart. So, 
inclusion or exclusion of the most basal slice, which 
consists of parts of LV myocardium, outflow tract, and 
left atrium, could be the main reason for the difference 
between previous studies and the present study [13]. 
Also, Feng Wang et al., (2009) and Faber et al., 
(2001), reported underestimation of EDV and ESV 
measured by cMRI and explained that, trabeculation 
and papillary muscles are clearly visualized on cardiac 
MRI images, so they are usually excluded from the 
volume on analysis of cardiac MRI images and that 
cMRI allows inclusion of outflow tract tissue, which is 
not a part of LV volume acquisition [10], [14]. On the 
other hand, Sugeng et al., (2006) and Jenkins et al., 
(2007) reported that real-time 3D echocardiography 
underestimated MRI-derived end-diastolic LV volume 
(mean 168 ml) by 15 ml while 2D echocardiography 
underestimated MRI derived end-diastolic LV volume 
by 57 ml [8], [15]. 
No statistically significant difference was 
found regarding Global LV hypokinesia (P = 0.255), 
septal wall dyskinesia (P = 0.217), inferior wall 
hypokinesia (P = 0.072) and inferior wall akinesia (P = 
0.349) measured by cMRI and 3D-STE. Hans-
Joachim Nesser et al., (2009) [12] reported that the 
new 3D-STE technology is likely to become the 
method of choice for the assessment of regional LV 
function, replacing TDI. However, for this to happen, 
3D-STE needs to be validated against an established 
reference technique. But because there is no non-
invasive ‘gold standard’ technique that can be used in 
human subjects to validate regional ventricular 
function in three dimensions, it is essential to test the 
accuracy of 3D-STE using a global index, such as LV 
volume, against the current standard CMR reference. 
This is the first study designed to address this need.  
In conclusion, automated 3D LV quantification 
echocardiography and 3D-STE are reliable tools in LV 
volumetric and systolic function assessment about 
CMRIas a standard method. 3D speckle 
echocardiography is comparable to CMRI in global 
wall hypokinesia detection but less sensitive in 
segmental wall hypokinesia assessment which 
mandates further studies. 
More objective techniques are needed for 
assessment of segmental wall hypokinesia. More 
studies are needed on a larger number of patients to 
validate normal values of 3D speckle in children. 
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